Kevin Sun
2017 - DexCom
In 2017, Kevin Sun earned a total compensation of $1.2M as Previous Interim Chief Financial Officer at DexCom.
Compensation breakdown
| Non-Equity Incentive Plan | $144,949 |
|---|---|
| Salary | $248,201 |
| Stock Awards | $753,363 |
| Other | $20,050 |
| Total | $1,166,563 |
Sun received $753.4K in stock awards, accounting for 65% of the total pay in 2017.
Sun also received $144.9K in non-equity incentive plan, $248.2K in salary and $20.1K in other compensation.
Rankings
In 2017, Kevin Sun's compensation ranked 8,236th out of 14,666 executives tracked by ExecPay. In other words, Sun earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,236 out of 14,666 | 44th |
Division Manufacturing | 3,112 out of 5,770 | 46th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 408 out of 856 | 52nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 217 out of 528 | 59th |
Industry Surgical and Medical Instruments and Apparatus | 132 out of 333 | 60th |
Source: SEC filing on April 20, 2018.
Sun's colleagues
We found eight more compensation records of executives who worked with Kevin Sun at DexCom in 2017.
2017
Kevin Sayer
DexCom
Chief Executive Officer
2017
Quentin Blackford
DexCom
Chief Financial Officer
2017
Terrance Gregg
DexCom
Chairman
2017
Andrew Balo
DexCom
EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development
2017
Donald Abbey
DexCom
EVP, Quality and Regulatory Affairs
2017
Steven Pacelli
DexCom
EVP, Strategy and Corporate Development
2017
Richard Doubleday
DexCom
EVP, Chief Commercial Officer
2017
Jess Roper
DexCom